Graig Suvannavejh Stock Analyst Profile - Mizuho Research Coverage - Stocknear

Graig Suvannavejh

Stock Analyst at Mizuho

(4.2)
# 1782
Out of 5,493 analysts
196
Total ratings
Success rate
Average return

46 Stocks

Name Action PT Current % Upside Ratings Updated
HRMY Harmony Biosciences ...
Maintains: Outperform
50 35
27.51 27.23% 19 Sep 25, 2025
IDYA IDEAYA Biosciences
Maintains: Outperform
43 44
26.83 64% 2 Sep 12, 2025
BTAI BioXcel Therapeutics
Maintains: Neutral
2 4
2.7 48.15% 9 Sep 12, 2025
KALA Kala Bio
Initiates Coverage On: Outperform
30
19.05 57.48% 1 Sep 8, 2025
INSM Insmed
Maintains: Outperform
130 165
137.03 20.41% 11 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
21 22
22.37 -1.65% 10 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
3 4
3.1 12.9% 5 Jul 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4 5
1.74 187.36% 2 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 12
4.51 166.08% 5 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
2 1
n/a n/a 3 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 10
8.08 23.76% 2 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 11
7.39 48.85% 3 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 26
13.9 87.05% 5 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
7 8
14.52 -44.9% 7 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
38 33
34.02 -3% 8 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
212 216
116.76 84.99% 21 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
140 132
n/a n/a 11 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7 8
1.56 387.18% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 74
12.11 511.07% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
50 5
3.84 30.21% 3 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
44 49
73.75 -33.56% 6 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 16
7.7 107.79% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25 45
n/a n/a 9 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 10
7.64 30.89% 5 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
274 258
n/a n/a 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 1
5.26 -80.99% 5 Jun 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
n/a n/a 1 Mar 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 35
99.16 -64.7% 5 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 8
15.8 -49.37% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
71 57
50.4 13.1% 2 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
8 5
35.5 -85.92% 4 Apr 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
n/a n/a 2 Oct 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 6
n/a n/a 2 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
53
n/a n/a 1 Jul 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
9.71 250.15% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
28
6.57 326.18% 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
16.05 93.15% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
380
33.62 1030.28% 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
5
1.79 165.36% 1 Nov 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
36
17.57 104.89% 2 Nov 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 1 Oct 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
37
1.5 2366.67% 1 Oct 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
128
127 0.79% 1 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 10
n/a n/a 1 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
29
n/a n/a 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
35
n/a n/a 1 Jan 8, 2020